Skip to main content
Clinical Trials/CTRI/2009/091/000590
CTRI/2009/091/000590
Recruiting
Phase 1

Stem cell therapy- Cellular Cardio myoplasty for patients with severe ventricular dysfunction

Frontier Lifeline PvtLtd0 sites90 target enrollmentTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Frontier Lifeline PvtLtd
Enrollment
90
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Frontier Lifeline PvtLtd

Eligibility Criteria

Inclusion Criteria

  • Patients aged between 0 to 60 years presenting with Dilated Cardiomyopathy or coronary artery disease (CAD) are enrolled. Patients with ventricular ejection fraction (LVEF) less than 35% are eligible for enrollement.

Exclusion Criteria

  • 1\. Sustained ventricular tachycardia in a 24 hour ECG.
  • 2\. Chronic atrial fibrillation.
  • 3\. Less than 6 months since last episode of cerebral
  • infarction.
  • 4\. Less than 6 months since last coronary angioplasty or
  • less than 3 months since last bypass surgery.
  • 5\. Patients with unstable angina, with a treatment rating
  • of 3 in the Braunwald system, but a severity of III and a
  • clinical rating of B or C.
  • 6\. Presence of left ventricular thrombus by

Outcomes

Primary Outcomes

Not specified

Similar Trials